Agile Therapeutics, Inc. (AGRX)

Analysts 5
Positive
100%
Median target $18 (96% upside)


  • Best rated in Drugs - Generic last 7 days

    more

    Users who viewed AGRX also viewed

    more

    Best rated stocks last 7 days

    more

    Most rated stocks last 72 hrs

    more